glp 1 receptor agonists and kidney protection GLP-1 the kidney: from physiology to pharmacology and outcomes in diabetes Renal protection with glucagon-like peptide-1

For over 30 years, 21st Century Vitamins has provided trusted vitamins and supplements by upholding the highest standards of quality in every product we offer

I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)

Explore how nutrition can support natural GLP-1 production, a hormone key to blood sugar regulation and weight management, often targeted by popular weight loss medications

Introduction The global obesity market is entering a new phase

GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.

To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist.